Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer.

Autor: Yu, Namhee1 (AUTHOR), Hwang, Mihwa1 (AUTHOR), Lee, Youngjoo1 (AUTHOR), Song, Bo Ram1 (AUTHOR), Kang, Eun Hye1 (AUTHOR), Sim, Hanna1 (AUTHOR), Ahn, Beung-Chul1 (AUTHOR), Hwang, Kum Hui1 (AUTHOR), Kim, Jihyun2 (AUTHOR), Hong, Sehwa1 (AUTHOR), Kim, Sunshin1 (AUTHOR) ksunshin@ncc.re.kr, Park, Charny1 (AUTHOR) charn78@ncc.re.kr, Han, Ji-Youn1 (AUTHOR) jymama@ncc.re.kr
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 1/30/2023, Vol. 42 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje